Michael Platten
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Biological Psychiatry top 0.02%
- Tryptophan and brain disorders
Papers in
- Genetics 194
- Glioma Diagnosis and Treatment 192
- Immunology 61
- Immunotherapy and Immune Responses 35
- T-cell and B-cell Immunology 13
- Immune cells in cancer 10
- Co-authors
- Wolfgang Wick (124 shared papers)Michael Weller (45 shared papers)Christiane A. Opitz (32 shared papers)Andreas von Deimling (39 shared papers)Francesca Fallarino (2 shared papers)Ellen A. A. Nollen (1 shared paper)Ute F. Röhrig (1 shared paper)Felix Sahm (37 shared papers)
- Journals
- Neuro-Oncology (47 papers)Acta Neuropathologica (15 papers)Nature Communications (11 papers)Nature (9 papers)Clinical Cancer Research (8 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Michael Platten
376 papers receiving 33.8k citations
Michael Platten's Hit Papers
Peers
Comparison fields: 5 of 159
- Genetics 14.9k
- Biological Psychiatry 1.9k
- Oncology 4.6k
- Immunology 3.6k
- Cancer Research 1.8k
Countries citing papers authored by Michael Platten
This map shows the geographic impact of Michael Platten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Platten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Platten more than expected).
Fields of papers citing papers by Michael Platten
This network shows the impact of papers produced by Michael Platten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Platten. The network helps show where Michael Platten may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Platten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 395 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA methylation-based classification of central nervous system tumours Hit paper breakdown → | 2018 | 2219 |
| 2 | An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Hit paper breakdown → | 2011 | 1617 |
| 3 | EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Hit paper breakdown → | 2020 | 1362 |
| 4 | Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond Hit paper breakdown → | 2019 | 1235 |
| 5 | Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Hit paper breakdown → | 2012 | 916 |
| 6 | Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Hit paper breakdown → | 2020 | 900 |
| 7 | Brain tumour cells interconnect to a functional and resistant network Hit paper breakdown → | 2015 | 889 |
| 8 | Actively personalized vaccination trial for newly diagnosed glioblastoma Hit paper breakdown → | 2018 | 778 |
| 9 | Lomustine and Bevacizumab in Progressive Glioblastoma Hit paper breakdown → | 2017 | 757 |
| 10 | DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis Hit paper breakdown → | 2017 | 655 |
| 11 | Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM Hit paper breakdown → | 2022 | 635 |
| 12 | 2012 | 616 | |
| 13 | A vaccine targeting mutant IDH1 induces antitumour immunity Hit paper breakdown → | 2014 | 611 |
| 14 | Aryl hydrocarbon receptor control of a disease tolerance defence pathway Hit paper breakdown → | 2014 | 609 |
| 15 | Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate Hit paper breakdown → | 2018 | 464 |
| 16 | MGMT testing—the challenges for biomarker-based glioma treatment Hit paper breakdown → | 2014 | 456 |
| 17 | Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience Hit paper breakdown → | 2018 | 418 |
| 18 | Sarcoma classification by DNA methylation profiling Hit paper breakdown → | 2021 | 398 |
| 19 | 2005 | 380 | |
| 20 | 2004 | 372 |
About Michael Platten
Michael Platten is a scholar working on Genetics, Immunology, Biological Psychiatry, Oncology and Pathology and Forensic Medicine, having authored 395 papers that have together received 34.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (192 papers), Cancer Immunotherapy and Biomarkers (51 papers), Multiple Sclerosis Research Studies (45 papers), Immunotherapy and Immune Responses (35 papers), Tryptophan and brain disorders (29 papers), T-cell and B-cell Immunology (13 papers), Immune cells in cancer (10 papers) and TGF-β signaling in diseases (9 papers). The work is most often cited by research in Genetics (14.9k citations), Biological Psychiatry (1.9k citations), Oncology (4.6k citations), Immunology (3.6k citations) and Cancer Research (1.8k citations). Michael Platten has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Wolfgang Wick, Michael Weller, Christiane A. Opitz, Andreas von Deimling, Francesca Fallarino, Ellen A. A. Nollen, Ute F. Röhrig, Felix Sahm, Benoı̂t J. Van den Eynde and Ulrike M. Litzenburger. Their work appears in journals such as Neuro-Oncology, Acta Neuropathologica, Nature Communications, Nature and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.